Shanghai Vitalgen BioPharma Co., Ltd.

Quick facts

Phase 3 pipeline

• VGR-R01 · Cardiovascular
  VGR-R01 is a small molecule drug that targets the renin-angiotensin system.

Phase 1 pipeline

• VGM-R02b
• VGN-R08b 1.68×10^14 vg
• VGN-R08b 4.2×10^13 vg
• VGN-R08b 8.4×10^13 vg
• VGN-R09b

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Shanghai Vitalgen BioPharma Co., Ltd. portfolio CI brief
• Shanghai Vitalgen BioPharma Co., Ltd. pipeline updates RSS